• Something wrong with this record ?

Enhanced antitumor activity of surface-modified iron oxide nanoparticles and an α-tocopherol derivative in a rat model of mammary gland carcinosarcoma

D. Horák, VI. Pustovyy, AV. Babinskyi, OM. Palyvoda, VF. Chekhun, IN. Todor, OI. Kuzmenko,

. 2017 ; 12 (-) : 4257-4268. [pub] 20170606

Language English Country New Zealand

Document type Journal Article

Maghemite (γ-Fe2O3) nanoparticles were obtained by coprecipitation of ferrous and ferric salts in an alkaline medium followed by oxidation; the nanoparticles were coated with poly(N,N-dimethylacrylamide) (PDMA) and characterized by transmission electron microscopy, attenuated total reflection (ATR) Fourier transform infrared (FTIR) spectroscopy, dynamic light scattering, thermogravimetric and elemental analyses, and magnetic measurements in terms of particle morphology, size, polydispersity, amount of coating, and magnetization, respectively. The effects of α-tocopherol (Toc) and its phenolic (Toc-6-OH) and acetate (Toc-6-Ac) derivatives on Fe2+ release from γ-Fe2O3@PDMA, as well as from γ-Fe2O3 and CuFe2O4 nanoparticles (controls), were examined in vitro using 1,10-phenanthroline. The presence of tocopherols enhanced spontaneous Fe2+ release from nanoparticles, with Toc-6-OH exhibiting more activity than neat Toc. All of the nanoparticles tested were found to initiate blood lipid oxidation in a concentration-dependent manner, as determined by analysis of 2-thiobarbituric acid reactive species. Wistar rats with Walker-256 carcinosarcoma (a model of mammary gland carcinosarcoma) received Toc-6-Ac, magnetic nanoparticles, or their combination per os, and the antitumor activity of each treatment was determined in vivo. γ-Fe2O3@PDMA nanoparticles exhibited increased antitumor activity compared to both commercial CuFe2O4 particles and the antitumor drug doxorubicin. Moreover, increased antitumor activity was observed after combined administration of γ-Fe2O3@PDMA nanoparticles and Toc-6-Ac; however, levels of bilirubin, aspartate aminotransferase, and white bloods normalized and did not differ from those of the intact controls. The antitumor activity of the γ-Fe2O3 nanoparticles strongly correlated with Fe2+ release from the nanoparticles but not with nanoparticle-initiated lipid peroxidation in vitro.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016515
003      
CZ-PrNML
005      
20180516135816.0
007      
ta
008      
180515s2017 nz f 000 0|eng||
009      
AR
024    7_
$a 10.2147/IJN.S137574 $2 doi
035    __
$a (PubMed)28652731
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a nz
100    1_
$a Horák, Daniel $u Department of Polymer Particles, Institute of Macromolecular Chemistry AS CR, Prague, Czech Republic.
245    10
$a Enhanced antitumor activity of surface-modified iron oxide nanoparticles and an α-tocopherol derivative in a rat model of mammary gland carcinosarcoma / $c D. Horák, VI. Pustovyy, AV. Babinskyi, OM. Palyvoda, VF. Chekhun, IN. Todor, OI. Kuzmenko,
520    9_
$a Maghemite (γ-Fe2O3) nanoparticles were obtained by coprecipitation of ferrous and ferric salts in an alkaline medium followed by oxidation; the nanoparticles were coated with poly(N,N-dimethylacrylamide) (PDMA) and characterized by transmission electron microscopy, attenuated total reflection (ATR) Fourier transform infrared (FTIR) spectroscopy, dynamic light scattering, thermogravimetric and elemental analyses, and magnetic measurements in terms of particle morphology, size, polydispersity, amount of coating, and magnetization, respectively. The effects of α-tocopherol (Toc) and its phenolic (Toc-6-OH) and acetate (Toc-6-Ac) derivatives on Fe2+ release from γ-Fe2O3@PDMA, as well as from γ-Fe2O3 and CuFe2O4 nanoparticles (controls), were examined in vitro using 1,10-phenanthroline. The presence of tocopherols enhanced spontaneous Fe2+ release from nanoparticles, with Toc-6-OH exhibiting more activity than neat Toc. All of the nanoparticles tested were found to initiate blood lipid oxidation in a concentration-dependent manner, as determined by analysis of 2-thiobarbituric acid reactive species. Wistar rats with Walker-256 carcinosarcoma (a model of mammary gland carcinosarcoma) received Toc-6-Ac, magnetic nanoparticles, or their combination per os, and the antitumor activity of each treatment was determined in vivo. γ-Fe2O3@PDMA nanoparticles exhibited increased antitumor activity compared to both commercial CuFe2O4 particles and the antitumor drug doxorubicin. Moreover, increased antitumor activity was observed after combined administration of γ-Fe2O3@PDMA nanoparticles and Toc-6-Ac; however, levels of bilirubin, aspartate aminotransferase, and white bloods normalized and did not differ from those of the intact controls. The antitumor activity of the γ-Fe2O3 nanoparticles strongly correlated with Fe2+ release from the nanoparticles but not with nanoparticle-initiated lipid peroxidation in vitro.
650    _2
$a akrylamidy $x chemie $7 D000178
650    _2
$a zvířata $7 D000818
650    _2
$a karcinosarkom $x farmakoterapie $7 D002296
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a lékové transportní systémy $x metody $7 D016503
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a železité sloučeniny $x chemie $7 D005290
650    _2
$a magnetické nanočástice $x aplikace a dávkování $x chemie $7 D058185
650    _2
$a experimentální nádory mléčných žláz $x farmakoterapie $7 D008325
650    _2
$a transmisní elektronová mikroskopie $7 D046529
650    _2
$a potkani Wistar $7 D017208
650    _2
$a spektroskopie infračervená s Fourierovou transformací $7 D017550
650    _2
$a alfa-tokoferol $x aplikace a dávkování $x chemie $7 D024502
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pustovyy, Vitaliy Igorovych $u Department of Vitamins and Coenzyme Biochemistry, Palladin Institute of Biochemistry, NASU, Ukraine.
700    1_
$a Babinskyi, Andrii Valeriyovich $u Department of Vitamins and Coenzyme Biochemistry, Palladin Institute of Biochemistry, NASU, Ukraine.
700    1_
$a Palyvoda, Olga Mikhailovna $u Department of Vitamins and Coenzyme Biochemistry, Palladin Institute of Biochemistry, NASU, Ukraine.
700    1_
$a Chekhun, Vasyl Fedorovich $u Department of Mechanisms of Antitumor Therapy, R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NASU, Ukraine.
700    1_
$a Todor, Igor Nikolaevich $u Department of Mechanisms of Antitumor Therapy, R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NASU, Ukraine.
700    1_
$a Kuzmenko, Oleksandr Ivanovich $u Department of Vitamins and Coenzyme Biochemistry, Palladin Institute of Biochemistry, NASU, Ukraine.
773    0_
$w MED00176143 $t International journal of nanomedicine $x 1178-2013 $g Roč. 12, č. - (2017), s. 4257-4268
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28652731 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180516135951 $b ABA008
999    __
$a ok $b bmc $g 1300139 $s 1013355
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 12 $c - $d 4257-4268 $e 20170606 $i 1178-2013 $m International journal of nanomedicine $n Int J Nanomedicine $x MED00176143
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...